The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
NRT, or Nicotine Replacement Therapy, refers to a range of smoking cessation aids that are designed to help individuals quit smoking by providing them with controlled doses of nicotine. NRT products are available in various forms, such as nicotine gum, patches, lozenges, nasal sprays, and inhalers. These aids work by delivering nicotine to the body without the harmful toxins and chemicals found in tobacco smoke, thereby reducing withdrawal symptoms and cravings associated with quitting smoking.
Global Nicotine Replacement Therapy for Smoking Cessation market is projected to reach US$ 727.3 million in 2029, increasing from US$ 524 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nicotine Replacement Therapy for Smoking Cessation market research.
Key companies engaged in the Nicotine Replacement Therapy for Smoking Cessation industry include Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon and Ventus Medical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nicotine Replacement Therapy for Smoking Cessation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nicotine Replacement Therapy for Smoking Cessation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nicotine Replacement Therapy for Smoking Cessation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Pfizer
- Cipla
- Novartis
- GlaxoSmithKline
- Johnson & Johnson
- Philip Morris
- Perrigo Company
- Alkalon
- Ventus Medical
Segment by Type
- Sprays and Inhalers
- Gums
- Patches
- Lozenges
Segment by Application
- Pharmacy
- Supermarket
- Hospital
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Nicotine Replacement Therapy for Smoking Cessation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sprays and Inhalers
1.2.3 Gums
1.2.4 Patches
1.2.5 Lozenges
1.3 Market by Application
1.3.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Supermarket
1.3.4 Hospital
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Perspective (2018-2029)
2.2 Nicotine Replacement Therapy for Smoking Cessation Growth Trends by Region
2.2.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nicotine Replacement Therapy for Smoking Cessation Historic Market Size by Region (2018-2023)
2.2.3 Nicotine Replacement Therapy for Smoking Cessation Forecasted Market Size by Region (2024-2029)
2.3 Nicotine Replacement Therapy for Smoking Cessation Market Dynamics
2.3.1 Nicotine Replacement Therapy for Smoking Cessation Industry Trends
2.3.2 Nicotine Replacement Therapy for Smoking Cessation Market Drivers
2.3.3 Nicotine Replacement Therapy for Smoking Cessation Market Challenges
2.3.4 Nicotine Replacement Therapy for Smoking Cessation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nicotine Replacement Therapy for Smoking Cessation Players by Revenue
3.1.1 Global Top Nicotine Replacement Therapy for Smoking Cessation Players by Revenue (2018-2023)
3.1.2 Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share by Players (2018-2023)
3.2 Global Nicotine Replacement Therapy for Smoking Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nicotine Replacement Therapy for Smoking Cessation Revenue
3.4 Global Nicotine Replacement Therapy for Smoking Cessation Market Concentration Ratio
3.4.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nicotine Replacement Therapy for Smoking Cessation Revenue in 2022
3.5 Nicotine Replacement Therapy for Smoking Cessation Key Players Head office and Area Served
3.6 Key Players Nicotine Replacement Therapy for Smoking Cessation Product Solution and Service
3.7 Date of Enter into Nicotine Replacement Therapy for Smoking Cessation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nicotine Replacement Therapy for Smoking Cessation Breakdown Data by Type
4.1 Global Nicotine Replacement Therapy for Smoking Cessation Historic Market Size by Type (2018-2023)
4.2 Global Nicotine Replacement Therapy for Smoking Cessation Forecasted Market Size by Type (2024-2029)
5 Nicotine Replacement Therapy for Smoking Cessation Breakdown Data by Application
5.1 Global Nicotine Replacement Therapy for Smoking Cessation Historic Market Size by Application (2018-2023)
5.2 Global Nicotine Replacement Therapy for Smoking Cessation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nicotine Replacement Therapy for Smoking Cessation Market Size (2018-2029)
6.2 North America Nicotine Replacement Therapy for Smoking Cessation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2018-2023)
6.4 North America Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nicotine Replacement Therapy for Smoking Cessation Market Size (2018-2029)
7.2 Europe Nicotine Replacement Therapy for Smoking Cessation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2018-2023)
7.4 Europe Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nicotine Replacement Therapy for Smoking Cessation Market Size (2018-2029)
8.2 Asia-Pacific Nicotine Replacement Therapy for Smoking Cessation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nicotine Replacement Therapy for Smoking Cessation Market Size by Region (2018-2023)
8.4 Asia-Pacific Nicotine Replacement Therapy for Smoking Cessation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nicotine Replacement Therapy for Smoking Cessation Market Size (2018-2029)
9.2 Latin America Nicotine Replacement Therapy for Smoking Cessation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2018-2023)
9.4 Latin America Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Market Size (2018-2029)
10.2 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2018-2023)
10.4 Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Nicotine Replacement Therapy for Smoking Cessation Introduction
11.1.4 Pfizer Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Cipla
11.2.1 Cipla Company Detail
11.2.2 Cipla Business Overview
11.2.3 Cipla Nicotine Replacement Therapy for Smoking Cessation Introduction
11.2.4 Cipla Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.2.5 Cipla Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Nicotine Replacement Therapy for Smoking Cessation Introduction
11.3.4 Novartis Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Introduction
11.4.4 GlaxoSmithKline Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Introduction
11.5.4 Johnson & Johnson Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Philip Morris
11.6.1 Philip Morris Company Detail
11.6.2 Philip Morris Business Overview
11.6.3 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Introduction
11.6.4 Philip Morris Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.6.5 Philip Morris Recent Development
11.7 Perrigo Company
11.7.1 Perrigo Company Company Detail
11.7.2 Perrigo Company Business Overview
11.7.3 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Introduction
11.7.4 Perrigo Company Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.7.5 Perrigo Company Recent Development
11.8 Alkalon
11.8.1 Alkalon Company Detail
11.8.2 Alkalon Business Overview
11.8.3 Alkalon Nicotine Replacement Therapy for Smoking Cessation Introduction
11.8.4 Alkalon Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.8.5 Alkalon Recent Development
11.9 Ventus Medical
11.9.1 Ventus Medical Company Detail
11.9.2 Ventus Medical Business Overview
11.9.3 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Introduction
11.9.4 Ventus Medical Revenue in Nicotine Replacement Therapy for Smoking Cessation Business (2018-2023)
11.9.5 Ventus Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
